Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 976
interventional 894
Observational 73
Registry 9

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 457
Drug|Other 50
Biological 44
Drug|Procedure 37
Biological|Drug 35
Biological|Drug|Procedure|Radiation 34
Biological|Drug|Procedure 30
Drug|Procedure|Radiation 26
Drug|placebo 21
Drug|Other|Procedure|Radiation 18
Procedure 17
Biological|Drug|Other|Procedure|Radiation 15
Biological|Drug|Other 14
Other 11
Device 7
Biological|Drug|Other|Procedure 6
Drug|Other|Procedure 6
Biological|Drug|Radiation 5
Biological|Other 5
Biological|Procedure 5
Drug|Genetic|Other 4
Drug|Radiation 4
Other|Procedure 4
Biological|Drug|Genetic|Other|Procedure 3
Biological|placebo 3
Dietary Supplement 3
Drug|Genetic|Other|Procedure 3
Biological|Drug|placebo 2
Dietary Supplement|Drug 2
Genetic 2
Behavioral|Dietary Supplement|Other|Procedure 1
Behavioral|Drug 1
Biological|Device|Drug|Procedure|Radiation 1
Biological|Device|Drug|Radiation 1
Biological|Dietary Supplement|Drug|Procedure 1
Biological|Genetic|Other 1
Biological|Genetic|Other|Procedure 1
Combination Product 1
Device|Drug 1
Device|Drug|Other|Procedure|Radiation 1
Device|Other 1
Diagnostic Test 1
Dietary Supplement|placebo 1
Drug|Genetic|Other|Procedure|Radiation 1
Drug|Genetic|Procedure|Radiation 1
Drug|Other|placebo 1
Drug|Other|placebo|Procedure 1
Drug|Other|Radiation 1
Drug|placebo|Procedure 1
Genetic|Radiation 1
Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 634
France 21
NA 18
Japan 14
United Kingdom 13
United States|Canada 13
Germany 11
Korea, Republic of 9
Canada 7
China 7
Italy 7
United States|France 7
Israel 5
Spain 5
Australia 4
United States|Germany 4
United States|Germany|Italy 3
United States|Italy 3
Belgium 2
Belgium|Netherlands 2
Brazil 2
France|Monaco 2
Netherlands 2
Russian Federation 2
Singapore 2
Taiwan 2
United States|Australia|Canada 2
United States|Belgium 2
United States|Denmark 2
Algeria|Argentina|Canada|China|Germany|Italy|Korea, Republic of|Spain|Sweden|United Kingdom 1
Australia|Austria|Belgium|Czechia|France|Israel|Japan|Spain 1
Australia|Bulgaria|France|Germany|Greece|Hungary|Italy|Netherlands|Poland|Spain|United Kingdom 1
Australia|France 1
Austria|Belgium|Czechia|France|Germany|Greece|Italy|Spain|Switzerland 1
Austria|Finland|Germany|Russian Federation 1
Belgium|Canada|Czech Republic|Finland|France|Germany|United States|Greece|Israel|Slovakia|Switzerland|Turkey|United Kingdom 1
Belgium|Czech Republic|France|Germany|Italy|Netherlands 1
Belgium|Czechia|France|Germany|Netherlands|Slovakia 1
Belgium|France|Germany|Israel|Italy|Netherlands|Spain|Sweden|United Kingdom 1
Belgium|France|Portugal 1
Belgium|Germany|Netherlands|Switzerland 1
Belgium|Germany|United Kingdom 1
Bulgaria|France|Germany|Greece|Russian Federation 1
Canada|United States|Australia|Netherlands|New Zealand|Puerto Rico|Switzerland 1
Denmark 1
Denmark|Norway|Sweden 1
Denmark|United Kingdom 1
Finland 1
France|Austria|Belgium|Czechia|Denmark|Germany|Ireland|Italy|Netherlands|Spain|Sweden|Switzerland|United Kingdom 1
France|Germany 1
France|Germany|Italy|Slovenia 1
France|Germany|Netherlands 1
France|Italy 1
France|Tunisia 1
Germany|Italy|Spain 1
Germany|Netherlands|United Kingdom 1
Germany|United States|Belgium|Canada|France|Italy|Netherlands|Spain|Sweden|Turkey|United Kingdom 1
Hong Kong 1
Hungary 1
Japan|Korea, Republic of 1
Japan|Korea, Republic of|Taiwan 1
Spain|United States|Australia|Bulgaria|Czechia|France|Germany|Greece|Hungary|Italy|Netherlands|Poland|Russian Federation|Sweden|United Kingdom 1
Sweden 1
Sweden|United States|Belgium|Canada|Czechia|Denmark|France|Germany|Italy|Japan|Korea, Republic of|Poland|Spain|United Kingdom 1
Switzerland 1
Thailand 1
United States|Argentina|Belgium|Brazil|Canada|Czechia|Germany|Greece|Hong Kong|Hungary|Ireland|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Poland|Puerto Rico|Russian Federation|Spain|Taiwan|Thailand 1
United States|Australia 1
United States|Australia|Austria|Belgium|Canada|Croatia|Czechia|Estonia|France|Germany|Hungary|India|Ireland|Israel|Italy|Japan|Poland|Russian Federation|Spain|Sweden|Switzerland|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|France|Germany|Israel|Italy|Japan|Lithuania|Netherlands|Poland|Portugal|Russian Federation|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|France|Germany|Israel|Italy|Japan|Poland|Portugal|Spain|Turkey|United Kingdom 1
United States|Australia|Belgium|Brazil|Canada|China|Czechia|France|Germany|Greece|Israel|Italy|Japan|Korea, Republic of|Mexico|Poland|Russian Federation|Spain|Turkey|United Kingdom 1
United States|Australia|Belgium|Brazil|Canada|Czechia|Denmark|Finland|France|Germany|Greece|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Norway|Poland|Portugal|Spain|Sweden|Turkey|United Kingdom 1
United States|Australia|Belgium|Czech Republic|Denmark|France|Germany|Greece|Italy|Netherlands|Russian Federation|Spain|Sweden|Switzerland|United Kingdom 1
United States|Australia|Belgium|France|Germany|Italy|Poland|Spain|United Kingdom 1
United States|Australia|Bulgaria|Canada|China|Denmark|Greece|Hong Kong|Italy|Malaysia|Mexico|New Zealand|Romania|Russian Federation|Switzerland|Thailand|United Kingdom 1
United States|Australia|Canada|France|Germany|Italy|Korea, Republic of|Spain|United Kingdom 1
United States|Australia|Canada|France|Germany|Italy|United Kingdom 1
United States|Australia|Canada|New Zealand|Puerto Rico|Saudi Arabia 1
United States|Australia|Canada|New Zealand|Saudi Arabia 1
United States|Australia|Canada|Puerto Rico 1
United States|Australia|Denmark|France|Germany|Italy|Spain|Sweden 1
United States|Australia|Finland|France|Germany|Netherlands|Spain|United Kingdom 1
United States|Australia|Finland|Italy|Singapore|Spain|Switzerland 1
United States|Australia|France|Germany|Italy|Japan|Netherlands 1
United States|Australia|France|Spain 1
United States|Australia|Germany 1
United States|Austria|Belgium|Canada|Czechia|France|Germany|Greece|Hong Kong|Hungary|Italy|Japan|Korea, Republic of|Norway|Spain|Sweden|Taiwan|Turkey|United Kingdom 1
United States|Austria|Belgium|Canada|France|Germany|Hungary|Italy|Korea, Republic of|Spain|Sweden|Switzerland|Thailand|United Kingdom 1
United States|Austria|Belgium|Canada|France|Germany|Italy|Netherlands|Poland|Portugal|Spain|United Kingdom 1
United States|Belgium|Bulgaria|Canada|Czechia|France|Germany|Ireland|Israel|Italy|Netherlands|Spain 1
United States|Belgium|Canada|Czechia|France|Germany|Israel|Italy|Korea, Republic of|Netherlands|Russian Federation|Spain|United Kingdom 1
United States|Belgium|Canada|France|Germany|United Kingdom 1
United States|Belgium|France|Germany|Italy|Spain 1
United States|Belgium|Italy|Netherlands|Russian Federation|Spain 1
United States|Brazil 1
United States|Brazil|Denmark|France|Germany|Hong Kong|Italy|Korea, Republic of|Puerto Rico|Taiwan|United Kingdom 1
United States|Brazil|France|Israel|Italy|Netherlands|Portugal|Singapore|Spain|United Kingdom 1
United States|Canada|France|Italy|Norway|Spain|United Kingdom 1
United States|Canada|France|Spain 1
United States|Canada|Germany|Italy|Poland|Spain 1
United States|Canada|New Zealand 1
United States|Canada|Puerto Rico 1
United States|Denmark|Germany 1
United States|France|Germany 1
United States|France|Germany|Spain 1
United States|France|Germany|United Kingdom 1
United States|France|United Kingdom 1
United States|Germany|Spain 1
United States|Israel 1
United States|Israel|Peru 1
United States|Korea, Republic of 1
United States|Singapore 1
United States|Spain 1
United States|Switzerland 1
United States|United Kingdom 1

Sites per Study

Site_count Study_Count
1 520
2 67
3 35
4 25
5 25
6 24
7 9
8 16
9 13
10 9
11 15
12 5
13 4
14 6
15 7
16 6
17 8
18 1
19 3
20 3
21 6
22 3
23 3
24 7
25 2
26 2
28 7
29 1
30 1
31 3
32 2
34 1
35 2
36 3
37 2
38 4
39 1
43 1
48 2
52 1
54 1
59 3
61 1
65 1
66 1
68 1
71 1
72 1
74 1
76 1
81 1
85 2
87 2
88 2
92 1
94 2
96 2
99 1
108 1
119 1
120 1
158 1
180 1
185 1
196 1
234 1
237 1
242 1
298 1
326 1
341 1
513 1

Phase

Phase Study_Count
Phase 2 370
Phase 1 250
Phase 1/Phase 2 123
Phase 3 74
N/A 51
Phase 4 14
Phase 2/Phase 3 8
Early Phase 1 4

Number of Arms

Number_of_Arms Count_of_Studies
1 459
2 172
3 43
4 21
5 14
6 10
7 4
9 2
10 1
11 1
NA 167

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 15.0 2.00000 1.00000 2.00000 3.00000 19 9.0000 21.00000
1st Qu. 22.5 23.00000 18.00000 30.00000 28.00000 134 135.0000 44.25000
Median 25.5 43.00000 30.00000 48.00000 50.00000 245 233.0000 71.00000
Mean 24.0 78.22917 39.55947 66.37931 74.52047 642 351.1304 93.71429
3rd Qu. 27.0 82.50000 48.00000 77.00000 96.00000 981 408.0000 112.50000
Max. 30.0 650.00000 302.00000 500.00000 455.00000 2000 2000.0000 309.00000

Trial Group Type

group_type Group_Count
Experimental 1039
NA 167
Active Comparator 97
Other 32
Placebo Comparator 29
No Intervention 15
Sham Comparator 1

Intervention Model

intervention_model Study_Count
Single Group Assignment 533
Parallel Assignment 206
NA 116
Sequential Assignment 24
Crossover Assignment 11
Factorial Assignment 4

Primary Purpose

primary_purpose Study_Count
Treatment 804
Supportive Care 52
Prevention 15
Other 5
NA 5
Basic Science 4
Health Services Research 4
Diagnostic 3
Screening 2

Observational Studies

Studies by Country

Country Study_Count
United States 32
France 8
Korea, Republic of 4
Spain 4
Italy 3
NA 3
Germany 2
Japan 2
United States|Australia|Canada 2
Austria|Croatia 1
Austria|Croatia|Czechia|Denmark|France|Germany|Greece|Israel|Italy|Netherlands|Poland|Portugal|Romania|Serbia|Spain|Sweden|Switzerland|United Kingdom 1
Austria|Germany 1
China 1
Denmark 1
Egypt 1
France|Germany|Italy|Spain 1
Mexico 1
Taiwan 1
United States|Austria|Belgium|Brazil|China|Croatia|Czechia|France|Germany|Italy|Taiwan|United Kingdom 1
United States|Canada 1
United States|Israel 1
United States|Puerto Rico 1

Sites per Study

Site_count Study_Count
1 32
2 9
3 2
4 1
6 3
7 2
8 1
12 2
13 1
15 1
16 1
18 1
19 1
20 1
25 1
43 1
45 1
48 1
50 1
53 1
66 1
70 1
96 1
137 1
142 1
225 1
234 1
280 1
292 1

Enrollment Metrics

Measure Observational
Min 8.00
1st Qu 60.00
Median 162.00
Mean 1003.25
3rd Qu 729.00
Max 15000.00

Observation Model

observational_model Study_Count
Cohort 28
Case-Only 19
Case-Control 9
NA 8
Other 7
Case Control 2

Time Perspective

time_perspective Study_Count
Prospective 52
NA 8
Cross-Sectional 5
Retrospective 5
Other 3

Registries

Studies by Country

Country Study_Count
United States 2
Austria 1
Belgium 1
Belgium|Denmark|France|Germany|Greece|Italy|Luxembourg|Norway|Spain|Sweden|United Kingdom 1
France 1
Germany 1
Hong Kong 1
Korea, Republic of 1

Sites per Study

Site_count Study_Count
1 6
2 1
21 1
135 1

Enrollment Metrics

Measure Registries
Min 48.000
1st Qu 130.000
Median 356.000
Mean 1658.111
3rd Qu 1000.000
Max 10000.000

Registry Model

observational_model Study_Count
Cohort 8
Case-Only 1

Time Perspective

time_perspective Study_Count
Prospective 8
Other 1

Follow-up

target_duration Study_Count
10 Years 2
12 Months 2
5 Years 2
1 Year 1
3 Years 1
6 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03233074 Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors https://ClinicalTrials.gov/show/NCT03233074 Recruiting Institut de Cancérologie de la Loire 2020-09-30
NCT03363399 Flow Cytometric Analysis of Peripheral Blood Neutrophil Myeloperoxidase Expression and Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT03363399 Completed University Hospital, Grenoble 2018-09-06
NCT02390414 The Myelodysplasia Transplantation-Associated Outcomes (MDS-TAO) Study https://ClinicalTrials.gov/show/NCT02390414 Active, not recruiting Dana-Farber Cancer Institute 2023-05-31
NCT03107273 Development of an in Vitro Hematopoietic Culture System and Application to Myelodysplastic Syndromes. https://ClinicalTrials.gov/show/NCT03107273 Completed Centre Hospitalier Universitaire, Amiens 2018-01-23
NCT03072498 Collection of Samples From Patients With MDS https://ClinicalTrials.gov/show/NCT03072498 Recruiting PersImmune, Inc 2020-12-05
NCT02921815 A Study to Analyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndrome Who Received Revlimid® 5 mg Capsules and Who Are Continuing or no Longer Continuing Revlimid Treatment https://ClinicalTrials.gov/show/NCT02921815 Active, not recruiting Celgene 2020-06-19
NCT02921802 A Study of Special Use Results Surveillance of Revlimid 5mg Capsules https://ClinicalTrials.gov/show/NCT02921802 Active, not recruiting Celgene 2020-06-19
NCT02842229 A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms https://ClinicalTrials.gov/show/NCT02842229 Completed Celgene 2017-02-02
NCT02775383 The National Myelodysplastic Syndromes (MDS) Study https://ClinicalTrials.gov/show/NCT02775383 Recruiting National Heart, Lung, and Blood Institute (NHLBI) 2021-09-30
NCT02378701 Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease https://ClinicalTrials.gov/show/NCT02378701 Active, not recruiting M.D. Anderson Cancer Center 2023-02-28
NCT02269592 Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome https://ClinicalTrials.gov/show/NCT02269592 Recruiting Dana-Farber Cancer Institute 2024-12-31
NCT02262312 Iron Overload and Transient Elastography in Patients With Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT02262312 Completed Zealand University Hospital 2015-06-30
NCT02137629 Post Marketing Surveillance to Collect and Evaluate the Safety and Efficacy Information of Korean MDS Patients Treated With VIDAZA®, After Approval of Marketing Authorization for New Drug in Korea https://ClinicalTrials.gov/show/NCT02137629 Completed Celgene 2016-05-19
NCT02085798 Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment) https://ClinicalTrials.gov/show/NCT02085798 Completed Celgene 2015-08-31
NCT02060409 Prognostic Molecular Markers in Patients With Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT02060409 Completed Samsung Medical Center 2013-10-31
NCT01311258 Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT01311258 Recruiting University of Rochester 2020-08-31
NCT01951430 Observational Evaluation of Infective Risk in Myelodysplastic Syndrome Patients https://ClinicalTrials.gov/show/NCT01951430 Recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2018-12-31
NCT01929408 Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients https://ClinicalTrials.gov/show/NCT01929408 Completed Fred Hutchinson Cancer Research Center 2018-12-04
NCT01911871 Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations https://ClinicalTrials.gov/show/NCT01911871 Completed Assistance Publique - Hôpitaux de Paris 2014-10-31
NCT01793675 Haplo-identical/Mismatched Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT01793675 Completed Peking University People’s Hospital 2012-12-31
NCT01739452 Spanish Registry of Erythropoietic Stimulating Agents Study https://ClinicalTrials.gov/show/NCT01739452 Completed Grupo Español de Síndromes Mielodisplásicos 2014-05-31
NCT01688011 Connect® MDS/AML Disease Registry https://ClinicalTrials.gov/show/NCT01688011 Recruiting Celgene 2022-12-12
NCT01595295 Registry on Hypomethylating Agents in Myeloid Neoplasms https://ClinicalTrials.gov/show/NCT01595295 Recruiting Arbeitsgemeinschaft medikamentoese Tumortherapie 2020-06-30
NCT01409070 Head to Head Comparison of Azacitidine and Decitabine in Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT01409070 Completed Seoul National University Hospital 2011-12-31
NCT01400633 An Observational Study for Dacogen Long-Term Treatment in Patients With Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT01400633 Completed Janssen Korea, Ltd., Korea 2014-03-31
NCT01355913 Screening and Genetic Monitoring of Patients With Myelodysplastic Syndromes (MDS) Under Different Treatment Modalities by Cytogenetic Analyses of Circulating CD34+Cells https://ClinicalTrials.gov/show/NCT01355913 Completed Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 2016-10-31
NCT04296214 Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT04296214 Recruiting Grupo Cooperativo de Hemopatías Malignas 2021-12-31
NCT04174547 An European Platform for Translational Research in Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT04174547 Recruiting Istituto Clinico Humanitas 2021-09-30
NCT04060485 Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results https://ClinicalTrials.gov/show/NCT04060485 Recruiting National Taiwan University Hospital 2024-08-31
NCT03894852 SRSF2 Gene Mutation in Patients With t-MDS/AML https://ClinicalTrials.gov/show/NCT03894852 Completed Assiut University 2019-12-29
NCT03659084 Study of the Outcome of Patients With Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Receiving Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT03659084 Recruiting Hospices Civils de Lyon 2018-04-30
NCT03621241 MODIFY (Mds DIagnosis Flow cYtometry) https://ClinicalTrials.gov/show/NCT03621241 Recruiting Centre Hospitalier Universitaire, Amiens 2021-06-15
NCT03526926 A Post-Marketing Observational Study of VYXEOSâ„¢ https://ClinicalTrials.gov/show/NCT03526926 Active, not recruiting Jazz Pharmaceuticals 2020-01-31
NCT03469661 Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS) https://ClinicalTrials.gov/show/NCT03469661 Recruiting Fundacion CRIS de Investigación para Vencer el Cáncer 2020-04-30
NCT01252485 Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms, and Higher Risk Myelodysplastic Syndrome - The Biology and Outcome (BiO)-Project https://ClinicalTrials.gov/show/NCT01252485 Recruiting University of Ulm NA
NCT01199562 Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT01199562 Completed City of Hope Medical Center 2013-12-31
NCT01146210 Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01146210 Completed Children’s Oncology Group 2016-05-31
NCT01137825 Registry of Older Patients With Cancer https://ClinicalTrials.gov/show/NCT01137825 Active, not recruiting UNC Lineberger Comprehensive Cancer Center 2030-06-30
NCT01137643 Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT01137643 Active, not recruiting UNC Lineberger Comprehensive Cancer Center 2040-07-31
NCT01095874 Allogeneic Hematopoietic Stem Cell Transplantation Evaluation in High Risk Myelodysplasia: an Observational Non-interventional Study https://ClinicalTrials.gov/show/NCT01095874 Completed Saint-Louis Hospital, Paris, France 2014-01-31
NCT01041846 A Study for Dacogen Treatment in Patients With Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT01041846 Completed Janssen Korea, Ltd., Korea 2010-07-31
NCT00996047 S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers https://ClinicalTrials.gov/show/NCT00996047 Completed Southwest Oncology Group 2012-01-31
NCT00987584 Phase II Cont. IV of ON 01910.Na in MDS w/ Trisomy 8/Intermed-1, 2/High Risk https://ClinicalTrials.gov/show/NCT00987584 Completed Stanford University 2011-01-31
NCT00967564 Survey on QUality of Life In myeloDisplasia (SQUID) https://ClinicalTrials.gov/show/NCT00967564 Completed Janssen-Cilag S.p.A. 2009-11-30
NCT00964821 Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00964821 Completed City of Hope Medical Center 2013-05-31
NCT00954720 Observational Study of Iron Overload in Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00954720 Completed Dana-Farber Cancer Institute 2011-01-31
NCT00919425 S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00919425 Completed Southwest Oncology Group 2012-01-31
NCT00899795 Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers https://ClinicalTrials.gov/show/NCT00899795 Completed OHSU Knight Cancer Institute 2010-10-31
NCT00899665 Proteases in Patients With Prostate Cancer That Has Spread to the Bone https://ClinicalTrials.gov/show/NCT00899665 Completed Barbara Ann Karmanos Cancer Institute 2006-09-30
NCT00899223 Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00899223 Active, not recruiting Alliance for Clinical Trials in Oncology 2020-12-31
NCT00898755 Collecting and Storing Tissue From Young Patients With Cancer https://ClinicalTrials.gov/show/NCT00898755 Completed Children’s Oncology Group 2008-07-17
NCT03558386 Study of Quality of Life in Older vs. Younger Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT03558386 Completed Center for International Blood and Marrow Transplant Research 2019-11-15
NCT04326023 Myelodysplastic Syndrome and Acute Myeloid Leukemia Related to PARP Inhibitors (MyeloRIB) https://ClinicalTrials.gov/show/NCT04326023 Completed University Hospital, Caen 2020-03-18
NCT00809575 Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00809575 Active, not recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2018-10-08
NCT01956799 Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy https://ClinicalTrials.gov/show/NCT01956799 Active, not recruiting Fondazione Italiana Sindromi Mielodisplastiche Onlus 2018-07-31
NCT01347944 MORE - Monitoring Revlimid - Collecting of Patient Information From Myelodysplastic Syndrome (MDS) Italian National Registry https://ClinicalTrials.gov/show/NCT01347944 Completed Celgene 2013-06-30
NCT03526666 Ascorbic Acid Levels in MDS, AML, and CMML Patients https://ClinicalTrials.gov/show/NCT03526666 Completed Van Andel Research Institute 2018-10-31
NCT00993694 Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone https://ClinicalTrials.gov/show/NCT00993694 Completed Vanderbilt University Medical Center 2009-12-31
NCT00723112 The Role of Erythropoietin in Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00723112 Completed University of Utah 2010-10-31
NCT00662090 Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood https://ClinicalTrials.gov/show/NCT00662090 Recruiting University Hospital Freiburg 2019-12-31
NCT00600860 A Prospective, Multicentre European Registry for Newly Diagnosed Patients With Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00600860 Recruiting Radboud University 2020-06-30
NCT00525746 Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS) https://ClinicalTrials.gov/show/NCT00525746 Active, not recruiting M.D. Anderson Cancer Center 2025-03-31
NCT00511537 Unrelated Stem Cell Transplantation for Adults With Hematopoietic Disorders https://ClinicalTrials.gov/show/NCT00511537 Completed University of California, San Francisco 2009-06-30
NCT00510315 Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00510315 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-01-31
NCT00504920 Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients https://ClinicalTrials.gov/show/NCT00504920 Completed M.D. Anderson Cancer Center 2008-09-30
NCT00459524 Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) https://ClinicalTrials.gov/show/NCT00459524 Completed M.D. Anderson Cancer Center 2009-03-31
NCT00281814 Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant https://ClinicalTrials.gov/show/NCT00281814 Completed The Cleveland Clinic 2008-12-31
NCT00281801 Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation https://ClinicalTrials.gov/show/NCT00281801 Completed Case Comprehensive Cancer Center 2008-12-31
NCT00195533 Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients https://ClinicalTrials.gov/show/NCT00195533 Completed Wyeth is now a wholly owned subsidiary of Pfizer 2005-03-31
NCT00126477 Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer https://ClinicalTrials.gov/show/NCT00126477 Completed Fred Hutchinson Cancer Research Center 2007-04-30
NCT00003790 Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00003790 Completed Children’s Oncology Group 2002-04-30
NCT00048958 Cytogenetic Studies in Acute Leukemia and Multiple Myeloma https://ClinicalTrials.gov/show/NCT00048958 Active, not recruiting Alliance for Clinical Trials in Oncology 2100-01-31
NCT00003793 Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma https://ClinicalTrials.gov/show/NCT00003793 Completed Children’s Oncology Group 2005-12-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03275480 Institut Paoli Calmettes Myelodysplastic Syndromes Database https://ClinicalTrials.gov/show/NCT03275480 Recruiting Institut Paoli-Calmettes 2030-01-31
NCT03169296 Clinical and Genomic Registry of MDS in Asia https://ClinicalTrials.gov/show/NCT03169296 Recruiting The University of Hong Kong 2022-06-30
NCT02867085 Study Investigating the Interactions of Bone and Hematopoiesis in the Elderly https://ClinicalTrials.gov/show/NCT02867085 Recruiting Technische Universität Dresden 2023-12-31
NCT02330692 Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and Relapse in Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT02330692 Recruiting Yonsei University 2023-07-31
NCT02279654 Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS Low or Int-1 MDS and Isolated Del(5q) https://ClinicalTrials.gov/show/NCT02279654 Active, not recruiting Celgene 2022-03-31
NCT01933035 Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias. https://ClinicalTrials.gov/show/NCT01933035 Completed Beth Israel Medical Center 2015-10-31
NCT01904175 Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant https://ClinicalTrials.gov/show/NCT01904175 Completed Duke University 2016-04-30
NCT04313231 Sterile Inflammation and Molecular Aberrations in MDS https://ClinicalTrials.gov/show/NCT04313231 Recruiting Medical University Innsbruck 2021-01-31
NCT04053933 Observational Study Towards the Impact of Newly Started Treatment in MDS on QoL https://ClinicalTrials.gov/show/NCT04053933 Recruiting University Hospital, Antwerp 2021-09-01